Loading
SP
Supreme Pharmaceuticals Inc. Stock: price and insider trades · Canada
Supreme Pharmaceuticals Inc.: what insiders have been doing
Supreme Pharmaceuticals Inc. is a listed company. Its insiders report their share dealings to SEDI. No insider at Supreme Pharmaceuticals Inc. has published a filing in the past twelve months. The most recent one dates from 15 November 2017.
Looking back to 2016, when coverage begins, insiders filed 9 purchases and 20 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
48
Thresholds
n/a
Buy Volume
€106,170
9 ops. · all time
Sell Volume
€408,424
20 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 15 November 2017
Declarations48 total
38,461 sharesCommon SharesTSXSEDI:3083779
769,230 sharesCommon SharesTSXSEDI:3083797
769,230 sharesCommon SharesTSXSEDI:3083796
26,923 sharesCommon SharesTSXSEDI:3083788
38,461 shares@ CA$1.360430.1% of flowCommon SharesTSXSEDI:3083781
Common SharesTSXSEDI:3036995
Common SharesTSXSEDI:3036978
16,800 shares@ CA$1.04614.7% of flowCommon SharesTSXSEDI:3036993
Canonical exit: 12 Oct 2017 (T+90)
20,000 shares@ CA$1.07923.4% of flowCommon SharesTSXSEDI:3036997
Canonical exit: 11 Oct 2017 (T+90)
16,800 shares@ CA$1.04619.1% of flowCommon SharesTSXSEDI:3037000
Canonical exit: 12 Oct 2017 (T+90)
20,000 shares@ CA$1.07918.0% of flowCommon SharesTSXSEDI:3036984
Canonical exit: 11 Oct 2017 (T+90)
Common SharesTSXSEDI:3036451
24,000 shares@ CA$1.08446.0% of flowCommon SharesTSXSEDI:3036473
Canonical exit: 11 Oct 2017 (T+90)
28,000 shares@ CA$1.09254.0% of flowCommon SharesTSXSEDI:3036588
Canonical exit: 11 Oct 2017 (T+90)
Common SharesTSXSEDI:3010070
Common SharesTSXSEDI:3010033
Common SharesTSXSEDI:2931022
40,472 shares@ CA$1.4411.3% of flowCommon SharesTSXSEDI:2903049
300,000 shares@ CA$0.4123.7% of flowCommon SharesTSXSEDI:2902326
20,000 shares@ CA$1.5426.6% of flowCommon SharesTSXSEDI:2902305
20,000 shares@ CA$1.4224.3% of flowCommon SharesTSXSEDI:2900397
99,900 shares@ CA$1.2223.4% of flowCommon SharesTSXSEDI:2900393
20,000 shares@ CA$1.3523.1% of flowCommon SharesTSXSEDI:2900395
20,000 shares@ CA$1.4124.1% of flowCommon SharesTSXSEDI:2900396
25,000 shares@ CA$1.065.1% of flowCommon SharesTSXSEDI:2897680
25 of 48 declarations
About Supreme Pharmaceuticals Inc.
Supreme Pharmaceuticals Inc. is a company focused on the research and development of pharmaceutical products. It is listed on the Toronto Stock Exchange under the symbol XTSE.
